Denise Kelly
Venture Partner @ Seventure Partners
Aberdeen, United Kingdom
Denise Kelly is a startup investor at Seventure Partners in Aberdeen. Denise joined Seventure Partners in September 2015 as a Consultant in the Life Sciences team for the microbiome field. Denise is currently based in Aberdeen, Scotland.As specialist in research on the human microbiome, she is responsible for relationships within the scientific and academic communities on behalf of Seventure Partners, identifyingnew investment opportunities in the field specific to the microbiome.Prior to joining Seventure, Denise led her own research team at the University of Aberdeen at the world renowned Rowett Institute. Denise has acquired more than 20 years of experience in intestinal microbiology and immunology. She was Founding President, General Manager, and Sales Director of GT Biologics, one of the first translational research spinouts developing innovative therapies from the microbiome.Her research is the source of many European and American patent applications. During her career, Denise worked with pharmaceutical and healthcare companies on several translational research projects.Denise received a BSc and a PhD from Queen’s University in Belfast. She is Professor Emeritus of the University of Aberdeen.
Last updated:
For AI agents: llms.txt
About Seventure Partners
Seventure Partners is a French venture capital firm targeting in Tech/Digital and Life Sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with € 1 billion undermanagement as of December 31, 2023. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.The different funds/verticals on which Seventure Partners are focusing on today: - Life Sciences : Biotech, Healthcare, Nutrition - Tech/Digital : B2B SaaS, Fintech, Retailtech, Cybersecurity - Sports & Wellbeing - Blue Economy
Seventure Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Adrien Caetano
Gestionnaire Middle & Back Office
|
|||
Ana Salas
assistant
|
|||
Bruno Rivet
General Partner & Associate Director
|
|||
David Manjarres
Head of ICT Department - General Partner
|
|||
|
Denise Kelly
Venture Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
